Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway

被引：0
|
作者：
Meichen Ma
Yue Pan
Yue Zhang
Mei Yang
Ying Xi
Baoxu Lin
Wudi Hao
Jianhua Liu
Lina Wu
Yong Liu
Xiaosong Qin
机构：
[1] Shengjing Hospital of China Medical University,Department of Laboratory Medicine
来源：
Journal of Cell Communication and Signaling | 2023年 / 17卷
关键词：
Idiopathic membranous nephropathy; Metformin; Rapamycin; AMPK/mTOR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1405 / 1415
页数：10
相关论文
共 50 条
  • [1] Metformin combined with rapamycin ameliorates podocyte injury in idiopathic membranous nephropathy through the AMPK/mTOR signaling pathway
    Ma, Meichen
    Pan, Yue
    Zhang, Yue
    Yang, Mei
    Xi, Ying
    Lin, Baoxu
    Hao, Wudi
    Liu, Jianhua
    Wu, Lina
    Liu, Yong
    Qin, Xiaosong
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2023, 17 (04) : 1405 - 1415
  • [2] Blockade of the mTOR signaling pathway with rapamycin ameliorates aristolochic acid nephropathy
    Wu, Minmin
    Tang, Lili
    Chen, Bicheng
    Zheng, Jianjian
    Dong, Fengquan
    Su, Zhen
    Lin, Fan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (04) : 2887 - 2894
  • [3] Emodin Ameliorates Renal Damage and Podocyte Injury in a Rat Model of Diabetic Nephropathy via Regulating AMPK/mTOR-Mediated Autophagy Signaling Pathway
    Liu, Hong
    Wang, Quan
    Shi, Ge
    Yang, Wenqiang
    Zhang, Yanmin
    Chen, Weidong
    Wan, Sheng
    Xiong, Fei
    Wang, Zengsi
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1253 - 1266
  • [4] Nuclear Receptor Coactivator 3 Deficiency Damages Podocyte Injury Through Targeting Fyn/AMPK/mTOR Signaling Pathway
    Xie Yaru
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 668 - 668
  • [5] Quercetin Ameliorates Myocardial Injury in Diabetic Rats by Regulating Autophagy and Apoptosis through AMPK/mTOR Signaling Pathway
    Chen, Yong-Feng
    Qiu, Qi
    Wang, Lei
    Li, Xiao-Rong
    Zhou, Shun
    Wang, Heng
    Jiang, Wen-Di
    Geng, Jia-Yi
    Tang, Bi
    Wang, Hong-Ju
    Kang, Pin-Fang
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (03): : 841 - 864
  • [6] The Role of AMPK/mTOR Signaling Pathway in Anticancer Activity of Metformin
    Chomanicova, Nikola
    Gazova, Andrea
    Adamickova, Adriana
    Valaskova, Simona
    Kyselovic, Jan
    PHYSIOLOGICAL RESEARCH, 2021, 70 (04) : 501 - 508
  • [7] The compound XueShuanTong promotes podocyte mitochondrial autophagy via the AMPK/mTOR pathway to alleviate diabetic nephropathy injury
    Zhang, Chuangbiao
    Ren, Weiwei
    Lu, Xiaohua
    Feng, Lie
    Li, Jiaying
    Zhu, Beibei
    MITOCHONDRION, 2025, 83
  • [8] Metformin Inhibits Abdominal Aortic Aneurysm Formation through the Activation of the AMPK/mTOR Signaling Pathway
    He, Jiaan
    Li, Nan
    Fan, Yichuan
    Zhao, Xingzhi
    Liu, Chengwei
    Hu, Xinhua
    JOURNAL OF VASCULAR RESEARCH, 2021, 58 (03) : 148 - 158
  • [9] Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
    Sorrenti, Vincenzo
    Benedetti, Francesca
    Buriani, Alessandro
    Fortinguerra, Stefano
    Caudullo, Giada
    Davinelli, Sergio
    Zella, Davide
    Scapagnini, Giovanni
    PHARMACEUTICALS, 2022, 15 (08)
  • [10] DsbA-L Ameliorates Renal Injury Through the AMPK/NLRP3 Inflammasome Signaling Pathway in Diabetic Nephropathy
    Yang, Ming
    Luo, Shilu
    Jiang, Na
    Wang, Xi
    Han, Yachun
    Zhao, Hao
    Xiong, Xiaofen
    Liu, Yan
    Zhao, Chanyue
    Zhu, Xuejing
    Sun, Lin
    FRONTIERS IN PHYSIOLOGY, 2021, 12
12345